Please Wait a Moment
X

Articles

25Jan

CTS implements Ortho VIP Viral Marker Testing Platform

25 Jan, 2021 | Return|
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the Prism to the VIP is one of the most significant changes we have made in the past three years. We implemented the new system through the dedication and extraordinary effort of everyone across the enterprise. Congratulations on this important success!

Related

Upcoming HCV Testing Algorithm Change

FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...

Read More >

Reminder-New Learning Center with New Content Launches on March 30!

The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...

Read More >

Preparing for Hurricane Florence

As the US coast prepares for Hurricane Florence to make landfall, we have received importan...

Read More >

Reminder- CTS Form Revisions Implement on September 2, 2019

Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...

Read More >

CTS conversion to the Ortho VERSEIA Integrated Processor (VIP) in January 2021

After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...

Read More >

FDA Guidance for Industry for Babesia

On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...

Read More >